Table 1.
Sonosensitizers | Probes | Biological Model | SDT Result | Imaging Effect | Ref. |
---|---|---|---|---|---|
PCF-MBs |
PCF | HT-29 cancer-bearing Balb/c nude mice |
tumor inhibition rate of more than 50% |
20 s post-injection, the US imaging signal reached the maximum; and the contrast enhancement could last for more than 3 min |
[49] |
FMSN-DOX |
FMSNs | TRAMP tumor-bearing nude mice |
The gradual reduction in tumor growth | from day 1 to day 9 with significant contrast enhancement within the tumor. | [45] |
HMME/MCC-HA |
MCC NPs | MCF-7 tumor-bearing nude mice | successfully suppressed the tumor volume with the V/V0 of 0.87 ± 0.13 |
strong US signals in tumor site at 3 h post-injection, and particularly after exposure to US stimulus |
[8] |
Lip-AIPH |
AIPH | MCF-7 tumor-bearing mice | a highly significant antitumor effect was achieved in mice in the group of Lip-AIPH with US irradiation |
a highly significant antitumor effect was achieved in mice in the group of Lip-AIPH with US irradiation |
[62] |
mTiO2@PPY-HNK |
mTiO2 | 4T1 tumor model | significantly inhibit the tumor growth | as the concentration increases, the ultrasound signal is more intense and the image is clearer | [63] |
OIX_NPs |
PFP | ID8 cells into the left shoulder (the primary tumor) |
significant inhibition of tumor volume | peaking at 4 h post-injection. | [64] |
TPZ/HMTNPs-SNO |
HMTNPs-SNO | MCF-7 tumor-bearing nude mice | exhibited an effective therapeutic effect |
compared with the saline group, showed local enhancement at the tumor site. | [65] |
IR780-NDs |
PFP | breast cancer 4T1 nude mice | Tumor weight drop | 24 h after the injection of IR780-NDs a bright US signal occurred at the tumor site. |
[47] |
SMISO NPs |
SMISO | 4T1 tumor-bearing nude mice | the inhibition rate of tumor growth in the SMISO + US group reached 88.2% |
the grayscale values of US images increase with them. concentration increases |
[66] |
RPPs&SPIOs |
RPPs | 4T1 tumors | a 100% survival rate of mice at 90 days | Shift in RPPs after thermal stimulation results in significant contrast enhancement | [67] |
FA-PEG-PLGA-Ptx@ICG-Pfh NPs |
Pfh | MDA-MB231 tumor-bearing mice | tumor growth was significantly inhibited | images were greatly improved | [68] |
RBC-HPBs/HMME/PFH |
PFH | 4T1 tumor-bearing female mice |
enhancing tumor treatment effects of HMME | A clear US signal was observed at 4 h after injection, and the strongest signal appeared at 8 h. | [69] |
Ce6-PFP-DTX/PLGA |
PFP | breast cancer 4T1 nude mice | much higher inhibition rate of the CPDP NPs + LIFU group | after LIFU irradiation, the corresponding intensity of CPDP NPs was elevated compared with the pre-irradiation group |
[70] |
AS1411-DOX-PFH-PEG@PLGA |
PFH | breast cancer 4T1 nude mice | the tumor volumes significantly decreased | Increased imaging ability of ADPPs in vivo within 24 h after intravenous injection | [71] |
RB-MBs |
MBs | HT-29 tumor mouse model |
- | a contrast-enhanced ultrasound imaging mode at a frequency of 5 MHz | [72] |